Dear editor,
Exosomes are the subpopulation of extracellular vesicles, originating from the plasma membrane. It is associated with cellular communication in healthy and pathological both phases [1]. Current decay, exosome-based research is the most emphasized field, and it explains pathological consequences dynamically. The relationship between cancer and exosomes are getting decoded gradually. It is built of many physiologically active components including DNA, RNA, protein, and lipid. This molecule regulates cancer in a more complex manner. In cancer, tumor derives exosomes (TDXs) has a relation with tumor microenvironment (TME) cell signalling. The groups of cellular alteration that take place such as developing uncontrol cellular proliferation, angiogenesis, metastasis, epithelial-mesenchymal transition (EMT) [2] and organ-specific metastasis [3]. Recent scientific findings mention that interestingly exosome and cancer stem cells are also interlinked [4]. TDXs reprogram the immune cells [5] dynamically. TDXs mediated macrophage 2 (M2) subpopulation polarization and promote EMT. It also alters the anticancer cytotoxic effect of cytotoxic T cells (Tc) and Natural killer cells (NK). TDXs change the Th17 and Treg cell population balance in the immune system which enhances the tumor development in the more aggressive pattern. Exosome surface integrin leads to organ-specific cancer metastasis. In cancer metastasis, one of the most vital events is extracellular matrix remodelling (EMC) and this event is also influenced via TDXs -associated molecules signature (fibronectin, integrin). The most exciting and complex cancer progression stage is EMT [6] which is regulated by TDXs-related active molecules such as miRNA, long noncoding RNA and circRNA. TDXs are the source of several cancer biomarkers. Exosome-based research transforms cancer biomarkers [7] research and introduces a new era of liquid biopsy. Exosome and nanotech combinations create a new generation of diagnostic tools, exosome-based drug delivery [8], and therapeutics for cancer. This innovative approach supports overcoming several cancer diagnostics barriers like early detection (exosome-based sensor) [9], specific drug delivery (Exosome surface modification) and low side effect drug (exosome are more biocompatible with non-toxic) [10] development.
In India, very micro-scale [11] exosome research activity is going on. According to several statistics of upcoming time, a large pullulation suffers from cancer in India. In future, exosomes may be the best option for dealing with cancer-associated health crises. All this evidence suggests exosome research might improve India's cancer treatment approach (cost-saving, early detection, more specific and efficient treatment). India has a high percentage of quality researchers, scientists and clinical expertise. It is important to create a work together ecosystem (where multidisciplinary scientific minds will work together for a better solution). It is also important to develop a good infrastructure for exosome researches. Based on exosome research, we may work together to confront impending health challenges creatively and effectively.
Ethical approval
Not needed. It is a letter.
Funding
None.
Author contribution
Conceptualization: Dattatreya Mukherjee, Writing: Rajib Dhar, Sukhamoy Gorai, Anand Krishnan, Review with Critical Comments: Anand Krishnan, Dattatreya Mukherjee, Editing: Dattatreya Mukherjee.
Registration of research studies
Name of the registry: NA
Unique Identifying number or registration ID: NA
Hyperlink to your specific registration (must be publicly accessible and will be checked): NA
Guarantor
All authors.
Consent
Not needed, It is a letter.
Declaration of competing interest
None.
Contributor Information
Rajib Dhar, Email: rajibdhar0001@gmail.com.
Sukhamoy Gorai, Email: sukhamoygorai1@gmail.com.
Anand Krishnan, Email: krishnana@ufs.ac.za.
Dattatreya Mukherjee, Email: dattatreyamukherjee4u@outlook.com.
References
- 1.Shao H., Im H., Castro C.M., et al. New technologies for analysis of extracellular vesicles. Chem. Rev. 2018 Feb 28;118(4):1917–1950. doi: 10.1021/acs.chemrev.7b00534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Xu R., Rai A., Chen M., et al. Extracellular vesicles in cancer — implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 2018;15:617–638. doi: 10.1038/s41571-018-0036-9. [DOI] [PubMed] [Google Scholar]
- 3.Hoshino A., Costa-Silva B., Shen T.L., et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329–335. doi: 10.1038/nature15756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Liu K., Gao X., Kang B., et al. The role of tumor stem cell exosomes in cancer invasion and metastasis. Front. Oncol. 2022 Mar 8;12 doi: 10.3389/fonc.2022.836548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zhou X., Xie F., Wang L., Zhang L., Zhang S., Fang M., Zhou F. The function and clinical application of extracellular vesicles in innate immune regulation. Cell. Mol. Immunol. 2020 Apr;17(4):323–334. doi: 10.1038/s41423-020-0391-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Syn N., Wang L., Sethi G., Thiery J.P., Goh B.C. Exosome-mediated metastasis: from epithelial-mesenchymal transition to escape from immunosurveillance. Trends Pharmacol. Sci. 2016 Jul;37(7):606–617. doi: 10.1016/j.tips.2016.04.006. [DOI] [PubMed] [Google Scholar]
- 7.Zhou B., Xu K., Zheng X., Chen T., Wang J., Song Y., Shao Y., Zheng S. Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct. Targeted Ther. 2020 Aug 3;5(1):144. doi: 10.1038/s41392-020-00258-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.de Jong O.G., Kooijmans S.A.A., Murphy D.E., Jiang L., Evers M.J.W., Sluijter J.P.G., Vader P., Schiffelers R.M. Drug delivery with extracellular vesicles: from imagination to innovation. Acc. Chem. Res. 2019 Jul 16;52(7):1761–1770. doi: 10.1021/acs.accounts.9b00109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang W., Tian Z., Yang S., et al. Electrochemical micro-aptasensors for exosome detection based on hybridization chain reaction amplification. Microsyst. Nanoeng. 2021;7:63. doi: 10.1038/s41378-021-00293-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lee J., Ha D., Cho B., Yi Y. A Toxicity study of exosomes derived from mesenchymal stem cells. Cytotherapy. 2020;22(5):S189. doi: 10.1016/j.jcyt.2020.04.044. [DOI] [Google Scholar]
- 11.Wang B., Xing D., Zhu Y., Dong S., Zhao B. The state of exosomes research: a global visualized analysis. BioMed Res. Int. 2019;3 doi: 10.1155/2019/1495130. 2019 Apr. [DOI] [PMC free article] [PubMed] [Google Scholar]